Document is current
Any future updates will be listed below
-
Authors
Albiñana, Clara https://orcid.org/0000-0002-3166-4120
Zhu, Zhihong
Schork, Andrew J.
Ingason, Andrés
Aschard, Hugues https://orcid.org/0000-0002-7554-6783
Brikell, Isabell
Bulik, Cynthia M. https://orcid.org/0000-0001-7772-3264
Petersen, Liselotte V.
Agerbo, Esben
Grove, Jakob https://orcid.org/0000-0003-2284-5744
Nordentoft, Merete
Hougaard, David M. https://orcid.org/0000-0001-5928-3517
Werge, Thomas https://orcid.org/0000-0003-1829-0766
Børglum, Anders D. https://orcid.org/0000-0001-8627-7219
Mortensen, Preben Bo https://orcid.org/0000-0002-5230-9865
McGrath, John J. https://orcid.org/0000-0002-4792-6068
Neale, Benjamin M. https://orcid.org/0000-0003-1513-6077
Privé, Florian https://orcid.org/0000-0002-3138-2078
Vilhjálmsson, Bjarni J. https://orcid.org/0000-0003-2277-9249
-
Funding
Funding for this research was provided by:
Danmarks Grundforskningsfond (Niels Bohr Profesorsship to John McGrath)
- License Information
-
More Information
Article History
Received: 11 January 2023
Accepted: 21 July 2023
First Online: 5 August 2023
Competing interests
: C.M.B. reports: Lundbeckfonden (grant recipient); Pearson (author, royalty recipient); Equip Health Inc. (Stakeholder Advisory Board). B.M.N. is a member of the scientific advisory board at Deep Genomics and Neumora, consultant of the scientific advisory board for Camp4 Therapeutics and consultant for Merck. B.J.V. is on Allelica’s international advisory board. The remaining authors declare no competing interests.
